vs
Side-by-side financial comparison of FVCBankcorp, Inc. (FVCB) and OCULAR THERAPEUTIX, INC (OCUL). Click either name above to swap in a different company.
FVCBankcorp, Inc. is the larger business by last-quarter revenue ($16.9M vs $13.3M, roughly 1.3× OCULAR THERAPEUTIX, INC). On growth, FVCBankcorp, Inc. posted the faster year-over-year revenue change (4377.5% vs -22.4%). FVCBankcorp, Inc. produced more free cash flow last quarter ($23.8M vs $-57.1M). Over the past eight quarters, FVCBankcorp, Inc.'s revenue compounded faster (586.6% CAGR vs -5.3%).
FVCBankcorp, Inc. is a Virginia-based U.S. bank holding company operating FVCbank, a community-focused financial institution. It provides a full range of personal and commercial banking products including deposit accounts, business and personal loans, mortgage services, and wealth management solutions, serving SMEs, professionals and individual consumers across the Mid-Atlantic region.
Ocular Therapeutix, Inc. is a biopharmaceutical firm specializing in developing and commercializing innovative ophthalmic therapies. Its products treat acute and chronic eye conditions including post-surgical pain, glaucoma, and dry eye, serving patients and ophthalmology providers primarily across the U.S. and select global markets.
FVCB vs OCUL — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $16.9M | $13.3M |
| Net Profit | — | $-64.7M |
| Gross Margin | — | 88.0% |
| Operating Margin | 43.7% | -526.5% |
| Net Margin | — | -488.0% |
| Revenue YoY | 4377.5% | -22.4% |
| Net Profit YoY | — | -33.6% |
| EPS (diluted) | $0.31 | $-0.27 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $16.9M | $13.3M | ||
| Q3 25 | $416.0K | $14.5M | ||
| Q2 25 | $15.8M | $13.5M | ||
| Q1 25 | $382.0K | $10.7M | ||
| Q4 24 | $378.0K | $17.1M | ||
| Q3 24 | $412.0K | $15.4M | ||
| Q2 24 | $415.0K | $16.4M | ||
| Q1 24 | $359.0K | $14.8M |
| Q4 25 | — | $-64.7M | ||
| Q3 25 | $5.6M | $-69.4M | ||
| Q2 25 | $5.7M | $-67.8M | ||
| Q1 25 | $5.2M | $-64.1M | ||
| Q4 24 | — | $-48.4M | ||
| Q3 24 | $4.7M | $-36.5M | ||
| Q2 24 | $4.2M | $-43.8M | ||
| Q1 24 | $1.3M | $-64.8M |
| Q4 25 | — | 88.0% | ||
| Q3 25 | — | 87.8% | ||
| Q2 25 | — | 85.6% | ||
| Q1 25 | — | 88.2% | ||
| Q4 24 | — | 92.8% | ||
| Q3 24 | — | 89.9% | ||
| Q2 24 | — | 90.8% | ||
| Q1 24 | — | 91.0% |
| Q4 25 | 43.7% | -526.5% | ||
| Q3 25 | — | -472.3% | ||
| Q2 25 | 45.9% | -502.6% | ||
| Q1 25 | — | -597.5% | ||
| Q4 24 | — | -296.1% | ||
| Q3 24 | — | -298.2% | ||
| Q2 24 | — | -265.1% | ||
| Q1 24 | — | -214.0% |
| Q4 25 | — | -488.0% | ||
| Q3 25 | 1341.1% | -477.3% | ||
| Q2 25 | 36.0% | -503.9% | ||
| Q1 25 | 1352.1% | -598.7% | ||
| Q4 24 | — | -283.3% | ||
| Q3 24 | 1133.3% | -236.6% | ||
| Q2 24 | 1001.2% | -266.3% | ||
| Q1 24 | 373.3% | -438.9% |
| Q4 25 | $0.31 | $-0.27 | ||
| Q3 25 | $0.31 | $-0.38 | ||
| Q2 25 | $0.31 | $-0.39 | ||
| Q1 25 | $0.28 | $-0.38 | ||
| Q4 24 | $0.27 | $-0.25 | ||
| Q3 24 | $0.25 | $-0.22 | ||
| Q2 24 | $0.23 | $-0.26 | ||
| Q1 24 | $0.07 | $-0.49 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $737.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $253.6M | $654.3M |
| Total Assets | $2.3B | $808.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $737.1M | ||
| Q3 25 | — | $344.8M | ||
| Q2 25 | — | $391.1M | ||
| Q1 25 | — | $349.7M | ||
| Q4 24 | — | $392.1M | ||
| Q3 24 | — | $427.2M | ||
| Q2 24 | — | $459.7M | ||
| Q1 24 | — | $482.9M |
| Q4 25 | $253.6M | $654.3M | ||
| Q3 25 | $249.8M | $258.2M | ||
| Q2 25 | $243.2M | $305.9M | ||
| Q1 25 | $242.3M | $265.9M | ||
| Q4 24 | $235.4M | $315.3M | ||
| Q3 24 | $230.8M | $352.0M | ||
| Q2 24 | $226.5M | $377.7M | ||
| Q1 24 | $220.7M | $408.0M |
| Q4 25 | $2.3B | $808.1M | ||
| Q3 25 | $2.3B | $410.9M | ||
| Q2 25 | $2.2B | $451.3M | ||
| Q1 25 | $2.2B | $405.9M | ||
| Q4 24 | $2.2B | $457.9M | ||
| Q3 24 | $2.3B | $490.4M | ||
| Q2 24 | $2.3B | $517.1M | ||
| Q1 24 | $2.2B | $538.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $23.9M | $-54.2M |
| Free Cash FlowOCF − Capex | $23.8M | $-57.1M |
| FCF MarginFCF / Revenue | 140.7% | -430.9% |
| Capex IntensityCapex / Revenue | 0.3% | 21.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $40.0M | $-216.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $23.9M | $-54.2M | ||
| Q3 25 | $7.6M | $-50.7M | ||
| Q2 25 | $3.3M | $-55.2M | ||
| Q1 25 | $5.4M | $-44.7M | ||
| Q4 24 | $18.2M | $-39.4M | ||
| Q3 24 | $4.7M | $-36.6M | ||
| Q2 24 | $1.6M | $-24.8M | ||
| Q1 24 | $7.2M | $-33.9M |
| Q4 25 | $23.8M | $-57.1M | ||
| Q3 25 | $7.6M | $-56.7M | ||
| Q2 25 | $3.3M | $-56.5M | ||
| Q1 25 | $5.4M | $-46.6M | ||
| Q4 24 | $18.1M | $-39.6M | ||
| Q3 24 | $4.6M | $-36.6M | ||
| Q2 24 | $1.5M | $-25.5M | ||
| Q1 24 | $7.1M | $-34.1M |
| Q4 25 | 140.7% | -430.9% | ||
| Q3 25 | 1818.0% | -390.0% | ||
| Q2 25 | 20.8% | -419.7% | ||
| Q1 25 | 1413.6% | -435.6% | ||
| Q4 24 | 4786.0% | -232.0% | ||
| Q3 24 | 1121.8% | -237.6% | ||
| Q2 24 | 361.2% | -155.4% | ||
| Q1 24 | 1988.3% | -231.1% |
| Q4 25 | 0.3% | 21.4% | ||
| Q3 25 | 0.2% | 41.2% | ||
| Q2 25 | 0.1% | 9.3% | ||
| Q1 25 | 4.2% | 18.1% | ||
| Q4 24 | 37.3% | 1.2% | ||
| Q3 24 | 14.1% | 0.6% | ||
| Q2 24 | 12.8% | 4.5% | ||
| Q1 24 | 3.9% | 1.7% |
| Q4 25 | — | — | ||
| Q3 25 | 1.36× | — | ||
| Q2 25 | 0.58× | — | ||
| Q1 25 | 1.05× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.00× | — | ||
| Q2 24 | 0.37× | — | ||
| Q1 24 | 5.34× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
